Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
10 pending office actions • 2 art units • 7 examiners • 0 of 10 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
LifeCell Corporation is currently managing 10 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are concentrated within 2 distinct art units, suggesting a technical scope for the company's current filings. The prosecution involves 7 distinct examiners, which means some examiners are handling multiple applications for the company.
The busiest examiner, BARIA, DINAH N, is currently responsible for 2 pending actions. With 10 pending office actions and 7 distinct examiners, the company must manage several different examination styles, although the concentration in 2 distinct art units may provide some consistency. This distribution requires the prosecution team to be mindful of the specific preferences of the 7 distinct examiners involved. Practitioners should focus on the standards of the 2 distinct art units while addressing the unique concerns raised by BARIA, DINAH N and the other examiners currently reviewing these 10 pending office actions in the Medical Devices & Mechanical Engineering sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (10%) |
| Double-patenting only | 1 (10%) |
| Double-patenting + other | 4 (40%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARIA, DINAH N | 2 | 72.9% | +28.5% |
| GHERBI, SUZETTE JAIME J | 2 | 85.0% | +8.8% |
| FOX, ALLISON M | 2 | 71.2% | +35.7% |
| PALLAY, MICHAEL B | 1 | 55.8% | +34.0% |
| LIU, TRACY | 1 | 54.5% | +27.3% |
| JOHNSON, KARA D | 1 | 69.5% | +24.6% |
| SAEED, ALI S | 1 | 31.3% | +35.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18783873 | BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES | GHERBI, SUZETTE JAIME J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | — |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | — |
| 18632995 | ADIPOSE TISSUE MATRIX WITH TROPOELASTIN | GHERBI, SUZETTE JAIME J | — |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16894261 | COATED POLYMERIC MATERIAL | SAEED, ALI S | 56d |
| 19028767 | ADIPOSE TISSUE MATRICES | PALLAY, MICHAEL B | — |
| 18922885 | NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS | LIU, TRACY | — |
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | — |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | — |
| 18641818 | PERFORATED TISSUE MATRIX | BARIA, DINAH N | — |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | — |
| 18386832 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | FOX, ALLISON M | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19028767 | ADIPOSE TISSUE MATRICES | PALLAY, MICHAEL B | 3774 | §112DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18922885 | NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS | LIU, TRACY | — | §103§112DP | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | — | §102§103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | — | §102§103 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18783873 | BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES | GHERBI, SUZETTE JAIME J | — | DP | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18641818 | PERFORATED TISSUE MATRIX | BARIA, DINAH N | — | §103§112DP | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18632995 | ADIPOSE TISSUE MATRIX WITH TROPOELASTIN | GHERBI, SUZETTE JAIME J | — | §102§103 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | — | §102§103 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18386832 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | FOX, ALLISON M | — | §112Other | Non-Final OA | — | Pending | Nov 03, 2023 |
| 16894261 | COATED POLYMERIC MATERIAL | SAEED, ALI S | 1616 | §103§112DP | Non-Final OA | 56d | Pending | Jun 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial